Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Inogen Inc. netted $52.5mm through the initial public offering of 3.5mm common shares at $16 each. Existing stockholders also sold 882k shares. Earlier this month the company had hoped to sell 4.4mm shares between $16-18. The twelve-year-old company develops, manufactures, and markets portable oxygen concentrators (POCs) that provide supplemental long-term oxygen to patients with chronic respiratory conditions.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?